Advertisement

Topics

BioInvent International AB and ThromboGenics NV Company Profile

23:00 EST 19th November 2017 | BioPortfolio

BioInvent International AB, listed on the NASDAQ OMX Stockholm (BINV), is a research-based


News Articles [87 Associated News Articles listed on BioPortfolio]

BioInvent And ThromboGenics NV Amending Long-Standing Monoclonal Antibody Development Agreement

  Life Sciences Jobs   ...

ThromboGenics NV And BioInvent Amending Long-Standing Monoclonal Antibody Development Agreement

  Life Sciences Jobs   ...

ThromboGenics NV: ThromboGenics NV: ThromboGenics Successfully Introduces New 'Already-Diluted' Formulation of JETREA® (ocriplasmin) in the US

Press release Leuven, Belgium, 28th September, 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for retinal disorders, with a focus on diabetic...

ThromboGenics NV: ThromboGenics NV: ThromboGenics Presenting THR-687 Preclinical Data at European Association for Vision and Eye Research (EVER) Meeting

Leuven, Belgium, 27th September, 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for retinal disorders, with a focus on diabetic eye disease, ...

ThromboGenics regains full global rights to Jetrea

ThromboGenics has regained full global rights to Jetrea from Alcon, according to a press release.Under the terms of the deal, ThromboGenics will receive 53.7 million euros in cash and an equity invest...

ThromboGenics NV : ThromboGenics Successfully Introduces New 'Already-Diluted' Formulation of JETREA® (ocriplasmin) in the US

Press release Leuven, Belgium, 28th September, 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for retinal disorders, with a focus on ...

ThromboGenics NV : ThromboGenics Presenting THR-687 Preclinical Data at European Association for Vision and Eye Research (EVER) Meeting

Leuven, Belgium, 27th September, 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for retinal disorders, with a focus on diabetic eye diseas...

ThromboGenics NV : ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)

Leuven, Belgium, 18th September, 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for retinal disorders, with a focus on diabetic eye disease...

Drugs and Medications [422 Associated Drugs and Medications listed on BioPortfolio]

Pvp iodine prep pad [Professional Disposables International, Inc.]

Drug Facts

Sani professional brand sani-hands for kids [Profesional Disposables International, Inc.]

SANI PROFESSIONAL BRAND SANI-HANDS FOR KIDS INSTANT HAND SANITIZING WIPES

Muscle and joint vanishing scent [LIFElabs, a Division of Atico International USA, INC.]

LIFElabs, a Division of Atico International USA, INC.

Sani-hands [Professional Disposables International, Inc.]

SANI PROFESSIONAL BRAND SANI-HANDS FOR KIDS INSTANT HAND SANITIZING WIPES

Pdi sani-hands for kids [Professional Disposables International, Inc.]

PDI SANI-HANDS FOR KIDS ANTIMICROBIAL ALCOHOL GEL HAND WIPES

PubMed Articles [685 Associated PubMed Articles listed on BioPortfolio]

Simplified Method for Local Correction of System International Normalized Ratio.

International normalized ratio (INR) derivation is dependent on the international sensitivity index (ISI) of thromboplastin. It varies with instrument and reagents used.

Gender and international clinician educators.

To describe gender differences of international clinician educators (CEs) and leaders, and CEs' perceptions by gender of preparation, roles, rewards and factors affecting job satisfaction and retentio...

Why You Should Become an International Academy of Compounding Pharmacists Member.

The International Academy of Compounding Pharmacists Introduces a New President.

International Academy of Compounding Pharmacists Legislative/Regulatory Update.

Clinical Trials [816 Associated Clinical Trials listed on BioPortfolio]

International AGD Database; Determinants of AGD and Establishment of Normative Data

Aim: To collate data on Anogenital Distance (AGD) from several population studies to build an international database for Anogenital Distance (AGD) Primary objective: To build a database p...

International Study on NoSocomial Pneumonia in Intensive CaRE

The International study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) is a prospective, international, multicentre, observational, cohort study. The study aims to provide up-to...

Effectiveness Study of the International Child Development Program

The objective of this study is to evaluate the effect of the International Child Development Program (ICDP). Research questions to be answered: 1. Does the ICDP affect children's psycho...

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

LCH III is an international, multicentric, prospective clinical study comprised of: - a randomized clinical trial for multisystem "RISK" patients and - a randomized clinical trial ...

Valiant Evo International Clinical Trial

The purpose of the Valiant Evo International Clinical Trial is to demonstrate the safety and effectiveness of the Valiant Evo Thoracic Stent Graft System in subjects with a descending thor...

Companies [1245 Associated Companies listed on BioPortfolio]

ThromboGenics NV and BioInvent International

ThromboGenics is a biotechnology company focused on the discovery and development of innovative biopharmaceuticals for the treatment of eye disease, vascular disease and cancer. The Company's lead...

BioInvent International AB and ThromboGenics NV

BioInvent International AB, listed on the NASDAQ OMX Stockholm (BINV), is a research-based

BioInvent

BioInvent International AB, listed on the NASDAQ OMX Stockholm (BINV), is a research-based pharmaceutical company that focuses on developing antibody drugs. The Company's pipeline...

Bioinvent International AB

BioInvent International is a unique company dedicated to working with clients to ensure their success in the discovery, development and manufacture of antibody drugs. The discovery of new drug targets...

BioInvent International AB (publ)

BioInvent is dedicated to helping realize the innovator's innovation originating from any drug discovery labs in corporate or academic environments. Based on this commitment, we actively seek collabor...

More Information about "BioInvent International AB and ThromboGenics NV" on BioPortfolio

We have published hundreds of BioInvent International AB and ThromboGenics NV news stories on BioPortfolio along with dozens of BioInvent International AB and ThromboGenics NV Clinical Trials and PubMed Articles about BioInvent International AB and ThromboGenics NV for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioInvent International AB and ThromboGenics NV Companies in our database. You can also find out about relevant BioInvent International AB and ThromboGenics NV Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record